European Companies Search Engine
EU funding (€148,500): EVOLchip - predicting antibiotic resistance for sustainable antibiotic stewardship Hor28 Aug 2017 EU Research and Innovation programme "Horizon"
Overview
Text
EVOLchip - predicting antibiotic resistance for sustainable antibiotic stewardship
Antibiotic resistance is rife (fig. 1), yet notoriously difficult to predict. Here I propose to assess the applied potential of an easy to use device, ‘EVOLchip’ that allows to test antibiotic treatment schemes within a few weeks for their risk of inducing antimicrobial resistance. If successful, this would allow to use current antibiotics much longer and to reuse old antibiotics in combination. Such tests can be conducted at hospital level by any trained medical microbiologist and hence be implemented into routine antibiotic stewardship. The proposed project entails (a) a praxis test with an enduser, a large university hospital, (b) an IPstrategy (c) a market and competitor analysis (d) a finance plan (e) a strategy to engage industrial partners and end-users.
Funded Companies:
| Company name | Funding amount |
| FREIE UNIVERSITAET BERLIN | €148,500 |
Source: https://cordis.europa.eu/project/id/768210
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Freie Universität Berlin, Berlin, Germany.
The visualizations for "FREIE UNIVERSITAET BERLIN - EU funding (€148,500): EVOLchip - predicting antibiotic resistance for sustainable antibiotic stewardship"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
